Therapeutic Segment:  Electrolytes

Generic Name:  Lactated Ringer and 5% Glucose Injection U.S.P.

Clinical Indication:

LAKSOL-RL (Lactated Ringer and 5% Glucose Injection) has value as a source of water for hydration, electrolytes and calories.

• Lactated Ringer’s and 5% Dextrose Injection, USP has value as a source of water, electrolytes, and calories. It is capable of inducing diuresis depending on the clinical condition of the patient.
• Lactated Ringer’s and 5% Dextrose Injection, USP produces a metabolic alkalinizing effect.
• Lactate is a substrate for gluconeogenesis. Administration of solutions containing dextrose and lactate should be used with caution in patients with impaired glucose tolerance and diabetes mellitus, as it may result in hyperglycemia.
• As for other calcium-containing infusion solutions, concomitant administration of ceftriaxone and Lactated Ringer’s and 5% Dextrose Injection, USP is contraindicated in newborns (≤ 28 days of age), even if separate infusion lines are used (risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream).
• In patients older than 28 days (including adults), ceftriaxone must not be administered simultaneously with intravenous calcium-containing solutions, including Lactated Ringer’s and 5% Dextrose Injection, USP, through the same infusion line (e.g., via Y-connector).
• Lactated Ringer’s and 5% Dextrose Injection, USP is contraindicated in patients with a known hypersensitivity to sodium lactate.

The choice of the specific electrolyte and glucose concentration, dosage, volume, rate and duration of administration depends on the age, weight, clinical condition of the patient and concomitant therapy. It should be determined by a physician.

Available as:

IV Drips

• 1000ml
• 500ml